期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
B超诊断视母细胞瘤二例
1
作者 邓云玖 张林芳 《吉林医学信息》 1994年第8期38-38,共1页
关键词 B超 诊断 视母细胞瘤
下载PDF
视网膜母细胞瘤的CT诊断 被引量:1
2
作者 何非 邵剑波 杨敏洁 《放射学实践》 1999年第2期102-103,共2页
目的:研究视网膜母细胞瘤的CT形态学改变,旨在提高对本病的认识。方法:对我院1995年8月~1997年12月的78例眼眶CT中初诊发现的23例眶内软组织肿块,其中11例视网膜母细胞瘤进行分析,8例经手术及病理证实,另... 目的:研究视网膜母细胞瘤的CT形态学改变,旨在提高对本病的认识。方法:对我院1995年8月~1997年12月的78例眼眶CT中初诊发现的23例眶内软组织肿块,其中11例视网膜母细胞瘤进行分析,8例经手术及病理证实,另3例因其它原因放弃治疗。结果:11例患儿均具有典型的CT表现:①眼球突出;②眼球壁上软组织密度块影;③团块状钙化。结论:CT表现对视网膜母细胞瘤的早期诊断、分期及手术提供了客观依据。 展开更多
关键词 母细胞 CT 诊断
下载PDF
小干扰RNA阻断周期蛋白依赖激酶4对子宫内膜癌细胞生物学行为的影响 被引量:2
3
作者 常军 刘玲芳 +1 位作者 郑殊娟 张婵 《中国癌症杂志》 CAS CSCD 北大核心 2014年第4期292-298,共7页
背景与目的:细胞周期蛋白依赖激酶4(cyclin-dependent kinase 4,CDK4)是调控细胞周期进程的重要激酶之一,有实验报道其在子宫内膜癌中呈高表达,但是其在子宫内膜癌细胞中的生物学功能及其可能机制还不十分明确。本研究旨在通过小干扰RNA... 背景与目的:细胞周期蛋白依赖激酶4(cyclin-dependent kinase 4,CDK4)是调控细胞周期进程的重要激酶之一,有实验报道其在子宫内膜癌中呈高表达,但是其在子宫内膜癌细胞中的生物学功能及其可能机制还不十分明确。本研究旨在通过小干扰RNA(small interfering RNA,siRNA)沉默CDK4表达,并检测其对人子宫内膜癌HEC-1B细胞生物学行为的影响及其可能机制。方法:将化学合成的CDK4-siRNA转染至HEC-1B细胞;实时荧光定量PCR法检测转染前后细胞中CDK4的mRNA表达量变化;Western blot检测转染前后细胞CDK4、视母细胞瘤基因(retinoblastoma gene,Rb)及其下游p-Rb的蛋白表达量的变化;分别采用CCK-8法、流式细胞仪、Transwell肿瘤细胞侵袭实验检测细胞增殖、周期、凋亡以及侵袭能力的变化。结果:转染后HEC-1B细胞中CDK4 mRNA及蛋白表达均明显下降(P<0.01);抑制CDK4表达后,抑制HEC-1B细胞的增殖及侵袭,转染si-CDK4组细胞发生侵袭数为(117±21)个,而转染si-control组及未处理组分别为(269±39)个和(262±35)个,差异具有统计学意义(P<0.01);细胞转染后早期凋亡率为(21.7±3.5)%,较未处理组[(12.4±2.1)%]和si-control组[(11.8±1.9)%]明显增加(P<0.01);细胞周期分布发生变化,G1期比例增加(P<0.01),S期细胞比例降低(P<0.01);进一步的Western blot结果显示,抑制CDK4表达后,细胞内p-Rb表达下降,但是总Rb表达无明显变化。结论:针对CDK4基因的特异性小RNA干扰片段能够下调CDK4基因在子宫内膜癌细胞中的表达,抑制肿瘤生物学进程。 展开更多
关键词 子宫内膜癌 RNA干扰 细胞周期蛋白依赖激酶4 视母细胞瘤基因 Cyclin-dependent KINASE 4
下载PDF
Visualizing the microtubule-associated protein tau in the nucleus 被引量:11
4
作者 LU Jing LI Ting +2 位作者 HE RongQiao BARTLETT Perry F GTZ Jürgen 《Science China(Life Sciences)》 SCIE CAS 2014年第4期422-431,共10页
Although tau is mainly known as an axonal microtubule-associated protein,many studies indicate that it is not restricted to this subcellular compartment.Assessing tau’s subcellular distribution,however,is not trivial... Although tau is mainly known as an axonal microtubule-associated protein,many studies indicate that it is not restricted to this subcellular compartment.Assessing tau’s subcellular distribution,however,is not trivial as is evident from transgenic mouse studies.When human tau is over-expressed,it can be immunohistochemically localized to axons and the somatodendritic domain,modeling what is found in neurodegenerative diseases such as Alzheimer’s disease.Yet,in wild-type mice,despite its abundance,tau is difficult to visualize even in the axon.It is even more challenging to detect this protein in the nucleus,where tau has been proposed to protect DNA from damage.To establish a framework for future studies into tau’s nuclear functions,we compared several methods to visualize endogenous nuclear tau in cell lines and mouse brain.While depending on the fixation and permeabilization protocol,we were able to detect nuclear tau in SH-SY5Y human neuroblastoma cells,we failed to do so in N2a murine neuroblastoma cells.As a second method we used subcellular fractionation of mouse tissue and found that in the nucleus tau is mainly present in a hypophosphorylated form.When either full-length or truncated human tau was expressed,both accumulated in the cytoplasm,but were also found in the nuclear fraction.Because subcellular fractionation methods have their limitations,we finally isolated nuclei to probe for nuclear tau and found that the nuclei were free of cytoplasmic contamination.Together our analysis identifies several protocols for detecting tau in the nucleus where it is found in a less phosphorylated form. 展开更多
关键词 Alzheimer's disease FRACTIONATION microtubule-associated protein NEUROBLASTOMA NUCLEUS PHOSPHORYLATION TAU
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部